ST-61219

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameST-61219
Drug Alias NameST-61219ST-479381
ClassificationSmall molecules
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsCandida Albicans InfectionsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Massachusetts
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnadys Pharmaceuticals IncUniversity of Massachusetts
Active IndicationsN/A
Inactive IndicationsCandida Albicans InfectionsMycoses

Other Information

ATC CodeN/A
Related LinksN/A